News Sentiment

TRAX sentiment intelligence

First Tracks Biotherapeutics news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 52 Balanced news tone 34 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 36.24 Week of 10 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

81/100 classification confidence.

Company focus 26

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+87.8% over one week, +105.4% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Neutral

First Tracks Biotherapeutics (TRAX) News Flow

Market Reaction

Price moving ahead of tone

61/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 81/100 classification
One-week reaction 87.8% Price confirming higher
Trend fit Trend inactive 105.4% over four weeks
Fair value 86.4% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 4
Neutral 29
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 26
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 6
Stock Titan 6
GlobeNewswire 5
MarketBeat 4
simplywall.st 2
MT Newswires 2
TradingView 2
Moomoo 1

Event Lens

What the news is about

Classified themes
Market update 19
Earnings 10
Analyst action 2
Balance sheet 2
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 34